Clinical features and outcomes of Legionnaires' disease in solid organ transplant recipients: Short communication

Transplant Infectious Disease

Volumn 11, Issue 1, 2009, Pages 78-82

  Gudiol, C ^a   Garcia Vidal, C ^a   Fernandez Sabe N ^a   Verdaguer, R ^a   Llado L ^a   Roca, J ^a   Gil Vernet, S ^a   Carratala J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Erythromycin; Immunosuppression; Legionella; Legionellosis; Legionnaires' disease; Levofloxacin; Solid organ transplantation; Urine antigen

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GRAFT RECIPIENT; HUMAN; LEGIONNAIRE DISEASE; MALE; MORTALITY; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; URINALYSIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; SPAIN;

EID: 58649114295     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2008.00337.x     Document Type: Article

References (21)

1. Garcia-Vidal C, Carratalà J. Current clinical management of Legionnaires' disease. Expert Rev Anti Infect Ther 2006 4 : 995 1004.
2. Chow JW, Yu VL. Legionella: a major opportunistic pathogen in transplant recipients. Semin Respir Infect 1998 13 : 132 139.
3. Singh N, Gayowski T, Wagener M, Marino IR, Yu VL. Pulmonary infections in liver transplant recipients receiving tacrolimus. Transplantation 1996 61 : 396 401.
4. Carratalà J, Gudiol F, Pallarès R, et al. Risk factors for nosocomial Legionella pneumophila pneumonia. Am J Respir Crit Care Med 1994 149 : 625 629.
5. Singh N, Stout JE, Yu VL. Prevention of Legionnaires' disease in transplant recipients: recommendations for a standardized approach. Transpl Infect Dis 2004 6 : 58 62.
6. Singh N, Muder RR, Yu VL, Gayowski T. Legionella infection in liver transplant recipients: implications for management. Transplantation 1993 56 : 1549 1551.
7. Bangsborg JM, Uldum S, Jensen JS, Bruun BG. Nosocomial legionellosis in three heart-lung transplant patients: case reports and environmental observations. Eur J Clin Microbiol Infect Dis 1995 14 : 99 104.
8. Sax H, Dharan S, Pittet D. Legionnaires' disease in a renal transplant recipient: nosocomial or home-grown? Transplantation 2002 74 : 890 892.
9. Fraser TG, Zembower TR, Lynch P, et al. Cavitary Legionella pneumonia in a liver transplant recipient. Transpl Infect Dis 2004 6 : 77 80.
10. Yu VL, Greenberg RN, Zadeikis N, et al. Levofloxacin efficacy in the treatment of community-acquired legionellosis. Chest 2004 125 : 2135 2139.
11. Mykietiuk A, Carratalà J, Fernández-Sabé N, et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis 2005 40 : 794 799.
12. Blázquez Garrido MR, Espinosa Parra FJ, Alemany Francés L, et al. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clin Infect Dis 2005 40 : 800 806.
13. Sabrià M, Pedro-Botet ML, Gómez J, et al. Fluoroquinolones vs macrolides in the treatment of Legionnaires disease. Chest 2005 128 : 1401 1405.
14. Tkatch LS, Kusne S, Irish WD, Krystofiak S, Wing E. Epidemiology of Legionella pneumonia and factors associated with Legionella-related mortality at a tertiary care center. Clin Infect Dis 1998 27 : 1479 1986.
15. Ampel NM, Wing EJ. Legionella infection in transplant patients. Semin Respir Infect 1990 5 : 30 37.
16. Prodinger WM, Bonatti H, Allerberg F, et al. Legionella pneumonia in transplant recipients: a cluster of cases of eight years' duration. J Hosp Infect 1994 26 : 191 202.
17. Heath CH, Grove DI, Looke DF. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis 1996 15 : 286 290.
18. Smith RP, Baltch AL, Franke M, Hioe W, Ritz W, Michelsen P. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes. J Antimicrob Chemother 1997 40 : 673 678.
19. Edelstein PH. Antimicrobial chemotherapy for legionnaires' disease: time for a change. Ann Intern Med 1998 129 : 328 330.
20. Roig J, Rello J. Legionnaires' disease: a rational approach to therapy. J Antimicrob Chemother 2003 5 : 1119 1129.
21. Horbach I, Fehrenbach FJ. Legionellosis in heart transplant recipients. Infection 1990 18 : 361 363.